292 related articles for article (PubMed ID: 34786218)
21. Polysensitivity and familiar occurrence in fixed drug eruption.
Bhargava P; Kuldeep CM; Mathur NK
Int J Dermatol; 1997 Mar; 36(3):236. PubMed ID: 9159016
[No Abstract] [Full Text] [Related]
22. Fixed drug eruption to sitagliptin.
Gupta M; Gupta A
J Diabetes Metab Disord; 2015; 14():18. PubMed ID: 25821748
[TBL] [Abstract][Full Text] [Related]
23. Drug Rash with Eosinophilia and Systemic Symptoms Syndrome Due to Anti-TB Medication.
Kaswala DH
J Family Med Prim Care; 2013 Jan; 2(1):83-5. PubMed ID: 24479051
[TBL] [Abstract][Full Text] [Related]
24. A double-blind, randomized trial, including frequent patient-physician contacts and Ramadan-focused advice, assessing vildagliptin and gliclazide in patients with type 2 diabetes fasting during Ramadan: the STEADFAST study.
Hassanein M; Abdallah K; Schweizer A
Vasc Health Risk Manag; 2014; 10():319-26. PubMed ID: 24920915
[TBL] [Abstract][Full Text] [Related]
25. Bioequivalence of vildagliptin/metformin fixed-dose combination tablets and a free combination of vildagliptin and metformin in healthy subjects.
He YL; Paladini S; Sabia H; Campestrini J; Zhang Y; Leon S; Ligueros-Saylan M; Jarugula V
Int J Clin Pharmacol Ther; 2008 May; 46(5):259-67. PubMed ID: 18538112
[TBL] [Abstract][Full Text] [Related]
26. Metformin-Induced Generalized Bullous Fixed-Drug Eruption with a Positive Dechallenge-Rechallenge Test: A Case Report and Literature Review.
Abtahi-Naeini B; Momen T; Amiri R; Rajabi P; Rastegarnasab F
Case Rep Dermatol Med; 2023; 2023():6353919. PubMed ID: 37034844
[TBL] [Abstract][Full Text] [Related]
27. Fixed Drug Eruption: An Underrecognized Cutaneous Manifestation of a Drug Reaction in the Primary Care Setting.
Shaker G; Mehendale T; De La Rosa C
Cureus; 2022 Aug; 14(8):e28299. PubMed ID: 36034061
[TBL] [Abstract][Full Text] [Related]
28. Effects of Anti-Diabetic Drugs on Fracture Risk: A Systematic Review and Network Meta-Analysis.
Zhang YS; Zheng YD; Yuan Y; Chen SC; Xie BC
Front Endocrinol (Lausanne); 2021; 12():735824. PubMed ID: 34721294
[TBL] [Abstract][Full Text] [Related]
29. Polysensitivity in fixed drug eruption due to a novel drug combination-independent lesions due to piroxicam and cotrimoxazole.
Ozkaya E
Eur J Dermatol; 2006; 16(5):591-2. PubMed ID: 17101493
[No Abstract] [Full Text] [Related]
30. Ivermectin-induced fixed drug eruption in an elderly Cameroonian: a case report.
Ngwasiri CA; Abanda MH; Aminde LN
J Med Case Rep; 2018 Sep; 12(1):254. PubMed ID: 30201032
[TBL] [Abstract][Full Text] [Related]
31. Cefotaxime induced generalized bullous fixed drug eruption - A case report.
Manikandan R; Porselvi A; Keerthana GC; Vaishnavi K; Girija S; Narasimhan M; Vijayakumar TM
Toxicol Rep; 2018; 5():1011-1013. PubMed ID: 30364669
[TBL] [Abstract][Full Text] [Related]
32. Fixed Drug Eruption Associated with Nonsteroidal Anti-Inflammatory Drugs for Menstrual Pain: A Case Report.
Shimizu R; Tsushima F; Komiya R; Yamagata Y; Harada H
Case Rep Dermatol; 2022; 14(1):6-11. PubMed ID: 35221960
[TBL] [Abstract][Full Text] [Related]
33. Treatment adherence with vildagliptin compared to sulphonylurea as add-on to metformin in Muslim patients with type 2 diabetes mellitus fasting during Ramadan.
Hanif W; Malik W; Hassanein M; Kamal A; Geransar P; Andrews C; Azam M; Barnett AH
Curr Med Res Opin; 2013 Jul; 29(7):807-11. PubMed ID: 23659561
[TBL] [Abstract][Full Text] [Related]
34. Polysensitivity in fixed drug eruption.
Shiohara T; Kokaji T
J Am Acad Dermatol; 1997 Dec; 37(6):1017-8. PubMed ID: 9418782
[No Abstract] [Full Text] [Related]
35. A 16-week study to compare the effect of vildagliptin versus gliclazide on postprandial lipoprotein concentrations and oxidative stress in patients with type 2 diabetes inadequately controlled with metformin monotherapy.
Hissa MR; Cavalcante LL; Guimarães SB; Hissa MN
Diabetol Metab Syndr; 2015; 7():62. PubMed ID: 26170902
[TBL] [Abstract][Full Text] [Related]
36. [Fixed drug eruption induced by sulfaguanidine].
Kastalli S; El Aidli S; Daghfous R; Trabelsi S; Lakhal M; Loueslati MH; Belkahia C
Ann Dermatol Venereol; 2004 Apr; 131(4):382-4. PubMed ID: 15258515
[TBL] [Abstract][Full Text] [Related]
37. Assessment of the efficacy and tolerability of a fixed dose combination of atorvastatin 10 mg + metformin SR 500 mg in diabetic dyslipidaemia in adult Indian patients.
Balasubramanian R; Varadharajan S; Kathale A; Nagraj LM; Periyandavar I; Nayak UP; Sharma A; Bolmall C; Baliga VP
J Indian Med Assoc; 2008 Jul; 106(7):464-7. PubMed ID: 18975505
[TBL] [Abstract][Full Text] [Related]
38. Postcoital fixed drug eruption in a man sensitive to trimethoprim-sulphamethoxazole.
Gruber F; Stasić A; Lenković M; Brajac I
Clin Exp Dermatol; 1997 May; 22(3):144-5. PubMed ID: 9425695
[TBL] [Abstract][Full Text] [Related]
39. Fixed Drug Eruption to Supplement Containing Ginkgo Biloba and Vinpocetine: A Case Report and Review of Related Cutaneous Side Effects.
Cohen PR
J Clin Aesthet Dermatol; 2017 Oct; 10(10):44-47. PubMed ID: 29344321
[No Abstract] [Full Text] [Related]
40. Case report: Generalized bullous fixed drug eruption mimicking epidermal necrolysis.
Paulmann M; Reinkemeier F; Lehnhardt M; Mockenhaupt M
Front Med (Lausanne); 2023; 10():1125754. PubMed ID: 37644986
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
